CELU · Celularity Inc. Class A Common Stock
View on chartInsiders & Stakes
| STARR INTERNATIONAL CO INC 10% Owner | ▼ Sell | Other | 15,281,389 Shares held | 3/1/2022 | View profile |
| Lim Kok Thay Director | ▼ Sell | Other | 6,335,630 Shares held | 1/24/2025 | View profile |
| Sorrento Therapeutics, Inc. 10% Owner | ▼ Sell | Open Market | 5,050,427 Shares held | 10/5/2023 | View profile |
| Robert J. Hariri Director | ▼ Sell | Tax Withholding | 2,853,553 Shares held | 4/13/2026 | View profile |
| Kilcoyne Adrian Chief Medical Officer | ▼ Sell | Tax Withholding | 1,122,238 Shares held | 2/17/2024 | View profile |
| SCULLEY JOHN Director | ▲ Buy | Grant | 1,004,660 Shares held | 6/14/2023 | View profile |
| Parks Diane L. Director | ▲ Buy | Grant | 520,021 Shares held | 1/12/2026 | View profile |
| Diamandis Peter Director | ▲ Buy | Grant | 394,150 Shares held | 1/12/2026 | View profile |
| Glover Bradley Chief Technology Officer | ▼ Sell | Tax Withholding | 351,192 Shares held | 4/13/2023 | View profile |
| VON ESCHENBACH ANDREW C. Director | ▲ Buy | Grant | 336,066 Shares held | 6/14/2023 | View profile |
| Dean C. Kehler Director | ▲ Buy | Grant | 303,482 Shares held | 12/19/2024 | View profile |
| Ling Geoffrey M.D. Director | ▲ Buy | Grant | 256,026 Shares held | 1/12/2026 | View profile |
| Marc Mazur Director | ▲ Buy | Grant | 236,066 Shares held | 6/14/2023 | View profile |
| Smith Robin L Director | ▲ Buy | Grant | 236,066 Shares held | 6/14/2023 | View profile |
| LeVien Vincent Director | ▲ Buy | Grant | 153,847 Shares held | 1/12/2026 | View profile |
| Richard J. Berman Director | ▲ Buy | Grant | 67,416 Shares held | 12/19/2024 | View profile |
| Jones Anne Chief Business Officer | ▼ Sell | Tax Withholding | 49,154 Shares held | 11/16/2022 | View profile |
| Haines John R See Remarks | ▼ Sell | Tax Withholding | 30,179 Shares held | 4/13/2026 | View profile |
| Fletcher Kyle General Counsel | ▼ Sell | Tax Withholding | 21,085 Shares held | 4/13/2024 | View profile |
| Beers David C Chief Financial Officer | ▼ Sell | Tax Withholding | 18,201 Shares held | 4/13/2025 | View profile |
| Dunn Keary See Remarks | ▲ Buy | Grant | 16,405 Shares held | 4/13/2022 | View profile |
| Brigido Stephen Pres, Functional Regeneration | ▼ Sell | Tax Withholding | 9,474 Shares held | 4/13/2026 | View profile |
Transaction History
| Brigido Stephen | ▲ Buy | Option Exercise | 821 | $0 | 4/13/2026 |
| Brigido Stephen | ▼ Sell | Tax Withholding | 268 | $343 | 4/13/2026 |
| Haines John R | ▲ Buy | Option Exercise | 1,641 | $0 | 4/13/2026 |
| Haines John R | ▼ Sell | Tax Withholding | 583 | $746 | 4/13/2026 |
| Robert J. Hariri | ▲ Buy | Option Exercise | 3,281 | $0 | 4/13/2026 |
| Robert J. Hariri | ▼ Sell | Tax Withholding | 1,182 | $2K | 4/13/2026 |
| Ling Geoffrey M.D. | ▲ Buy | Grant | 19,231 | $0 | 1/12/2026 |
| LeVien Vincent | ▲ Buy | Grant | 28,847 | $0 | 1/12/2026 |
| Diamandis Peter | ▲ Buy | Grant | 20,385 | $0 | 1/12/2026 |
| Parks Diane L. | ▲ Buy | Grant | 30,000 | $0 | 1/12/2026 |
| Ling Geoffrey M.D. | ▲ Buy | Grant | 125,000 | $0 | 12/29/2025 |
| Parks Diane L. | ▲ Buy | Grant | 125,000 | $0 | 12/29/2025 |
| Diamandis Peter | ▲ Buy | Grant | 125,000 | $0 | 12/29/2025 |
| LeVien Vincent | ▲ Buy | Grant | 125,000 | $0 | 12/29/2025 |
| Parks Diane L. | ▲ Buy | Grant | 67,416 | $0 | 12/19/2025 |
| Ling Geoffrey M.D. | ▲ Buy | Grant | 67,416 | $0 | 12/19/2025 |
| Diamandis Peter | ▲ Buy | Grant | 67,416 | $0 | 12/19/2025 |
| Ling Geoffrey M.D. | ▲ Buy | Grant | 44,379 | $0 | 11/19/2025 |
| Parks Diane L. | ▲ Buy | Grant | 61,539 | $0 | 11/19/2025 |
| LeVien Vincent | ▲ Buy | Grant | 3,699 | $0 | 11/19/2025 |
| Diamandis Peter | ▲ Buy | Grant | 47,042 | $0 | 11/19/2025 |
| Brigido Stephen | ▲ Buy | Option Exercise | 820 | $0 | 4/13/2025 |
| Brigido Stephen | ▼ Sell | Tax Withholding | 268 | $440 | 4/13/2025 |
| Robert J. Hariri | ▲ Buy | Option Exercise | 3,281 | $0 | 4/13/2025 |
| Robert J. Hariri | ▼ Sell | Tax Withholding | 1,154 | $2K | 4/13/2025 |
| Haines John R | ▲ Buy | Option Exercise | 1,641 | $0 | 4/13/2025 |
| Haines John R | ▼ Sell | Tax Withholding | 577 | $946 | 4/13/2025 |
| Beers David C | ▲ Buy | Option Exercise | 1,025 | $0 | 4/13/2025 |
| Beers David C | ▼ Sell | Tax Withholding | 360 | $590 | 4/13/2025 |
| Beers David C | ▼ Sell | Tax Withholding | 4,396 | $9K | 2/17/2025 |
| Haines John R | ▼ Sell | Tax Withholding | 7,035 | $15K | 2/17/2025 |
| Haines John R | ▲ Buy | Option Exercise | 20,000 | $0 | 2/17/2025 |
| Brigido Stephen | ▲ Buy | Option Exercise | 10,000 | $0 | 2/17/2025 |
| Brigido Stephen | ▼ Sell | Tax Withholding | 3,272 | $7K | 2/17/2025 |
| Beers David C | ▲ Buy | Option Exercise | 12,500 | $0 | 2/17/2025 |
| Lim Kok Thay | ▼ Sell | Other | 652,981 | $1.4M | 1/24/2025 |
| Lim Kok Thay | ▼ Sell | Other | 535,274 | $1.1M | 1/24/2025 |
| Parks Diane L. | ▲ Buy | Grant | 67,416 | $0 | 12/19/2024 |
| Ling Geoffrey M.D. | ▲ Buy | Grant | 67,416 | $0 | 12/19/2024 |
| Dean C. Kehler | ▲ Buy | Grant | 67,416 | $0 | 12/19/2024 |
| Richard J. Berman | ▲ Buy | Grant | 67,416 | $0 | 12/19/2024 |
| Diamandis Peter | ▲ Buy | Grant | 67,416 | $0 | 12/19/2024 |
| Brigido Stephen | ▼ Sell | Tax Withholding | 268 | $1K | 4/13/2024 |
| Fletcher Kyle | ▼ Sell | Tax Withholding | 20 | $82 | 4/13/2024 |
| Haines John R | ▼ Sell | Tax Withholding | 576 | $2K | 4/13/2024 |
| Beers David C | ▼ Sell | Tax Withholding | 360 | $1K | 4/13/2024 |
| Robert J. Hariri | ▼ Sell | Tax Withholding | 1,154 | $5K | 4/13/2024 |
| Fletcher Kyle | ▼ Sell | Tax Withholding | 617 | $4K | 3/15/2024 |
| Kilcoyne Adrian | ▼ Sell | Tax Withholding | 52,762 | $23K | 2/17/2024 |
| Haines John R | ▼ Sell | Tax Withholding | 70,350 | $31K | 2/17/2024 |
| Beers David C | ▼ Sell | Tax Withholding | 43,968 | $19K | 2/17/2024 |
| Fletcher Kyle | ▼ Sell | Tax Withholding | 39,571 | $17K | 2/17/2024 |
| Brigido Stephen | ▼ Sell | Tax Withholding | 32,720 | $14K | 2/17/2024 |
| Lim Kok Thay | ▲ Buy | Open Market | 21,410,983 | $5.3M | 1/12/2024 |
| Robert J. Hariri | ▲ Buy | Open Market | 3,050,427 | $484K | 10/5/2023 |
| Sorrento Therapeutics, Inc. | ▼ Sell | Open Market | 6,307,158 | — | 10/5/2023 |
| Robert J. Hariri | ▲ Buy | Open Market | 6,307,158 | $1.0M | 10/5/2023 |
| Robert J. Hariri | ▲ Buy | Open Market | 9,064,539 | $1.5M | 9/29/2023 |
| Sorrento Therapeutics, Inc. | ▼ Sell | Open Market | 9,064,539 | — | 9/29/2023 |
| Kilcoyne Adrian | ▲ Buy | Grant | 875,000 | $0 | 7/14/2023 |
| Parks Diane L. | ▲ Buy | Grant | 199,921 | $0 | 6/14/2023 |
| Dean C. Kehler | ▲ Buy | Grant | 199,921 | $0 | 6/14/2023 |
| Smith Robin L | ▲ Buy | Grant | 199,921 | $0 | 6/14/2023 |
| Marc Mazur | ▲ Buy | Grant | 199,921 | $0 | 6/14/2023 |
| VON ESCHENBACH ANDREW C. | ▲ Buy | Grant | 199,921 | $0 | 6/14/2023 |
| SCULLEY JOHN | ▲ Buy | Grant | 199,921 | $0 | 6/14/2023 |
| Diamandis Peter | ▲ Buy | Grant | 199,921 | $0 | 6/14/2023 |
| Lim Kok Thay | ▲ Buy | Grant | 199,921 | $0 | 6/14/2023 |
| Brigido Stephen | ▼ Sell | Tax Withholding | 2,683 | $2K | 4/13/2023 |
| Fletcher Kyle | ▼ Sell | Tax Withholding | 201 | $144 | 4/13/2023 |
| Beers David C | ▼ Sell | Tax Withholding | 3,606 | $3K | 4/13/2023 |
| Haines John R | ▼ Sell | Tax Withholding | 5,770 | $4K | 4/13/2023 |
| Glover Bradley | ▼ Sell | Tax Withholding | 2,884 | $2K | 4/13/2023 |
| Robert J. Hariri | ▼ Sell | Tax Withholding | 11,540 | $8K | 4/13/2023 |
| Robert J. Hariri | ▲ Buy | Grant | 2,084,854 | $1.7M | 3/27/2023 |
| Fletcher Kyle | ▼ Sell | Tax Withholding | 2,170 | $1K | 3/15/2023 |
| Fletcher Kyle | ▲ Buy | Grant | 225,000 | — | 2/17/2023 |
| Haines John R | ▲ Buy | Grant | 400,000 | — | 2/17/2023 |
| Beers David C | ▲ Buy | Grant | 250,000 | — | 2/17/2023 |
| Glover Bradley | ▲ Buy | Grant | 300,000 | — | 2/17/2023 |
| Brigido Stephen | ▲ Buy | Grant | 200,000 | — | 2/17/2023 |
| Kilcoyne Adrian | ▲ Buy | Grant | 300,000 | — | 2/17/2023 |
| Diamandis Peter | ▲ Buy | Option Exercise | 1,071,000 | $300K | 2/10/2023 |
| Robert J. Hariri | ▲ Buy | Open Market | 10,000 | $17K | 11/30/2022 |
| Robert J. Hariri | ▲ Buy | Open Market | 40,000 | $68K | 11/29/2022 |
| Robert J. Hariri | ▲ Buy | Open Market | 40,000 | $70K | 11/28/2022 |
| Jones Anne | ▼ Sell | Tax Withholding | 3,734 | $7K | 11/16/2022 |
| Fletcher Kyle | ▼ Sell | Tax Withholding | 1,262 | $2K | 11/16/2022 |
| SCULLEY JOHN | ▲ Buy | Option Exercise | 768,594 | $215K | 8/26/2022 |
| Robert J. Hariri | ▲ Buy | Option Exercise | 119,073 | $342K | 8/24/2022 |
| Diamandis Peter | ▲ Buy | Grant | 36,145 | $0 | 7/13/2022 |
| SCULLEY JOHN | ▲ Buy | Grant | 36,145 | $0 | 7/13/2022 |
| Lim Kok Thay | ▲ Buy | Grant | 36,145 | $0 | 7/13/2022 |
| Dean C. Kehler | ▲ Buy | Grant | 36,145 | $0 | 7/13/2022 |
| Glover Bradley | ▲ Buy | Grant | 13,124 | $0 | 7/13/2022 |
| Marc Mazur | ▲ Buy | Grant | 36,145 | $0 | 7/13/2022 |
| Parks Diane L. | ▲ Buy | Grant | 36,145 | $0 | 7/13/2022 |
| Jones Anne | ▲ Buy | Grant | 11,483 | $0 | 7/13/2022 |
| Fletcher Kyle | ▲ Buy | Grant | 2,297 | $0 | 7/13/2022 |
| Smith Robin L | ▲ Buy | Grant | 36,145 | $0 | 7/13/2022 |
| VON ESCHENBACH ANDREW C. | ▲ Buy | Grant | 36,145 | $0 | 7/13/2022 |
| Jones Anne | ▲ Buy | Grant | 16,405 | — | 4/13/2022 |
| Glover Bradley | ▲ Buy | Grant | 19,686 | — | 4/13/2022 |
| Beers David C | ▲ Buy | Grant | 41,011 | — | 4/13/2022 |
| Haines John R | ▲ Buy | Grant | 65,617 | — | 4/13/2022 |
| Robert J. Hariri | ▲ Buy | Grant | 131,234 | — | 4/13/2022 |
| Dunn Keary | ▲ Buy | Grant | 16,405 | — | 4/13/2022 |
| Brigido Stephen | ▲ Buy | Grant | 32,809 | — | 4/13/2022 |
| STARR INTERNATIONAL CO INC | ▼ Sell | Other | 6,640,694 | $23.2M | 3/1/2022 |
| Jones Anne | ▲ Buy | Grant | 25,000 | $0 | 11/16/2021 |
| Glover Bradley | ▲ Buy | Grant | 25,000 | $0 | 11/16/2021 |
| Glover Bradley | ▼ Sell | Tax Withholding | 3,734 | $7K | 11/16/2021 |
| VON ESCHENBACH ANDREW C. | ▲ Buy | Option Exercise | 100,000 | $28K | 11/9/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Celularity Q1 2027 EPS Up, Announces Partner & Board Member
Celularity posted a first‑quarter 2027 earnings per share of $0.02, up from a loss of $0.84 a year earlier, while sales fell to $3.85 million from $11.43 million. The company will open the Fontaine Vitale facility with its strategic partner and added Naveen Jain to its board. It also closed a $10 million private placement of senior secured convertible notes and warrants, part of a $28 million recapitalization plan.
Celularity Q1 2027 EPS Up, Announces Partner & Board Member. Celularity posted a first‑quarter 2027 earnings per share of $0.02, up from a loss of $0.84 a year earlier, while sales fell to $3.85 million from $11.43 million. The company will open the Fontaine Vitale facility with its strategic partner and added Naveen Jain to its board. It also closed a $10 million private placement of senior secured convertible notes and warrants, part of a $28 million recapitalization plan.